NDC Pharmacologic Class N0000175761 Monoamine Oxidase-B Inhibitors [MoA]
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0187-0453 | Zelapar | Selegiline Hydrochloride | Tablet, Orally Disintegrating | Oral | Valeant Pharmaceuticals North America Llc | Human Prescription Drug |
0378-9290 | Selegiline Hydrochloride | Selegiline Hydrochloride | Tablet | Oral | Mylan Pharmaceuticals Inc. | Human Prescription Drug |
27505-110 | Xadago | Safinamide Mesylate | Tablet, Film Coated | Oral | Us Worldmeds, Llc | Human Prescription Drug |
27505-111 | Xadago | Safinamide Mesylate | Tablet, Film Coated | Oral | Us Worldmeds, Llc | Human Prescription Drug |
49502-900 | Emsam | Selegiline | Patch | Transdermal | Mylan Specialty L.p. | Human Prescription Drug |
49502-901 | Emsam | Selegiline | Patch | Transdermal | Mylan Specialty L.p. | Human Prescription Drug |
49502-902 | Emsam | Selegiline | Patch | Transdermal | Mylan Specialty L.p. | Human Prescription Drug |
51862-146 | Selegiline Hydrochloride | Selegiline Hydrochloride | Tablet | Oral | Mayne Pharma | Human Prescription Drug |
60429-019 | Selegiline Hydrochloride | Selegiline Hydrochloride | Capsule | Oral | Golden State Medical Supply, Inc. | Human Prescription Drug |
60429-176 | Selegiline Hydrochloride | Selegiline Hydrochloride | Tablet | Oral | Golden State Medical Supply, Inc. | Human Prescription Drug |
60505-0055 | Selegiline Hydrochloride | Selegiline Hydrochloride | Capsule | Oral | Apotex Corp. | Human Prescription Drug |
60505-3438 | Selegiline Hydrochloride | Selegiline Hydrochloride | Tablet | Oral | Apotex Corp. | Human Prescription Drug |
67253-700 | Selegiline Hydrochloride | Selegiline Hydrochloride | Capsule | Oral | Par Pharmaceutical | Human Prescription Drug |
68151-2649 | Selegiline Hydrochloride | Selegiline Hydrochloride | Capsule | Oral | Carilion Materials Management | Human Prescription Drug |
There are 14 NDC products with the pharmacologic class Monoamine Oxidase-B Inhibitors [MoA].